Concurrently, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for all insiders. The closure period is from June 24, 2026, to July 24, 2026, with both dates inclusive. This is a standard procedure to prevent insider trading around the period of financial results declaration.
The disclosure was signed by K Randhir Singh, who holds the positions of Company Secretary, Compliance Officer & Head-CSR for Dr. Reddy's Laboratories Limited.